A national coverage decision is expected Oct. 1, Silverman said. Prior to the findings of the study being presented, there was no rigorously controlled scientific evidence available that examined the long-term clinical benefit connected with obtaining a Family pet scan, or any additional kind of neuroimaging, in the evaluation of declining patients. This multi-center, prospective, randomized and blinded research demonstrates significant clinical advantage, which may save health care dollars also. ‘Patients who don't have Alzheimer's disease may be prescribed drugs that won't help them, or even make sure they are worse,’ Silverman said.Strathearn says the factors that help shape the advancement of the oxytocin system in the brain may predispose to successful breastfeeding and nurturance of the baby and understanding early relationship factors that might help prevent maternal neglect, which is very important for society both in developing intervention strategies for moms and preventing possible long-term developmental problems for children. The extensive research team included Dr. Abdullah Dr and Mamun. Jake Najman from the University of Queensland, Australia and Dr. Michael O’Callaghan of Mater Misericordiae Children’s Hospital in Brisbane, Australia. The study was backed by grants from the Queensland Federal government Department of Child Safety, the Australian National Health insurance and Medical Research Council and america National Institute of Child Health insurance and Human Development.